Targeting metabolism of breast cancer and its implications in T cell immunotherapy

Breast cancer is a prominent health issue amongst women around the world. Immunotherapies including tumor targeted antibodies, adoptive T cell therapy, vaccines, and immune checkpoint blockers have rejuvenated the clinical management of breast cancer, but the prognosis of patients remains dismal. Me...

Full description

Bibliographic Details
Main Authors: Jialuo Zou, Cunjun Mai, Zhiqin Lin, Jian Zhou, Guie Lai
Format: Article
Language:English
Published: Frontiers Media S.A. 2024-04-01
Series:Frontiers in Immunology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2024.1381970/full
_version_ 1797213506490073088
author Jialuo Zou
Cunjun Mai
Zhiqin Lin
Jian Zhou
Guie Lai
author_facet Jialuo Zou
Cunjun Mai
Zhiqin Lin
Jian Zhou
Guie Lai
author_sort Jialuo Zou
collection DOAJ
description Breast cancer is a prominent health issue amongst women around the world. Immunotherapies including tumor targeted antibodies, adoptive T cell therapy, vaccines, and immune checkpoint blockers have rejuvenated the clinical management of breast cancer, but the prognosis of patients remains dismal. Metabolic reprogramming and immune escape are two important mechanisms supporting the progression of breast cancer. The deprivation uptake of nutrients (such as glucose, amino acid, and lipid) by breast cancer cells has a significant impact on tumor growth and microenvironment remodeling. In recent years, in-depth researches on the mechanism of metabolic reprogramming and immune escape have been extensively conducted, and targeting metabolic reprogramming has been proposed as a new therapeutic strategy for breast cancer. This article reviews the abnormal metabolism of breast cancer cells and its impact on the anti-tumor activity of T cells, and further explores the possibility of targeting metabolism as a therapeutic strategy for breast cancer.
first_indexed 2024-04-24T10:59:22Z
format Article
id doaj.art-1b9b5d044a214d948b9d1593f754ba3a
institution Directory Open Access Journal
issn 1664-3224
language English
last_indexed 2024-04-24T10:59:22Z
publishDate 2024-04-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Immunology
spelling doaj.art-1b9b5d044a214d948b9d1593f754ba3a2024-04-12T04:14:49ZengFrontiers Media S.A.Frontiers in Immunology1664-32242024-04-011510.3389/fimmu.2024.13819701381970Targeting metabolism of breast cancer and its implications in T cell immunotherapyJialuo Zou0Cunjun Mai1Zhiqin Lin2Jian Zhou3Guie Lai4Department of Breast Disease Comprehensive Center, First Affiliated Hospital of Gannan Medical University, Gannan Medical University, Ganzhou, Jiangxi, ChinaDepartment of Breast Disease Comprehensive Center, First Affiliated Hospital of Gannan Medical University, Gannan Medical University, Ganzhou, Jiangxi, ChinaDepartment of Breast Disease Comprehensive Center, First Affiliated Hospital of Gannan Medical University, Gannan Medical University, Ganzhou, Jiangxi, ChinaDepartment of Immunology, International Cancer Center, Shenzhen University Health Science Center, Shenzhen University, Shenzhen, Guangdong, ChinaDepartment of Breast Disease Comprehensive Center, First Affiliated Hospital of Gannan Medical University, Gannan Medical University, Ganzhou, Jiangxi, ChinaBreast cancer is a prominent health issue amongst women around the world. Immunotherapies including tumor targeted antibodies, adoptive T cell therapy, vaccines, and immune checkpoint blockers have rejuvenated the clinical management of breast cancer, but the prognosis of patients remains dismal. Metabolic reprogramming and immune escape are two important mechanisms supporting the progression of breast cancer. The deprivation uptake of nutrients (such as glucose, amino acid, and lipid) by breast cancer cells has a significant impact on tumor growth and microenvironment remodeling. In recent years, in-depth researches on the mechanism of metabolic reprogramming and immune escape have been extensively conducted, and targeting metabolic reprogramming has been proposed as a new therapeutic strategy for breast cancer. This article reviews the abnormal metabolism of breast cancer cells and its impact on the anti-tumor activity of T cells, and further explores the possibility of targeting metabolism as a therapeutic strategy for breast cancer.https://www.frontiersin.org/articles/10.3389/fimmu.2024.1381970/fullbreast cancerT cell immunotherapymetabolic reprogrammingimmune escapeglucoseamino acid
spellingShingle Jialuo Zou
Cunjun Mai
Zhiqin Lin
Jian Zhou
Guie Lai
Targeting metabolism of breast cancer and its implications in T cell immunotherapy
Frontiers in Immunology
breast cancer
T cell immunotherapy
metabolic reprogramming
immune escape
glucose
amino acid
title Targeting metabolism of breast cancer and its implications in T cell immunotherapy
title_full Targeting metabolism of breast cancer and its implications in T cell immunotherapy
title_fullStr Targeting metabolism of breast cancer and its implications in T cell immunotherapy
title_full_unstemmed Targeting metabolism of breast cancer and its implications in T cell immunotherapy
title_short Targeting metabolism of breast cancer and its implications in T cell immunotherapy
title_sort targeting metabolism of breast cancer and its implications in t cell immunotherapy
topic breast cancer
T cell immunotherapy
metabolic reprogramming
immune escape
glucose
amino acid
url https://www.frontiersin.org/articles/10.3389/fimmu.2024.1381970/full
work_keys_str_mv AT jialuozou targetingmetabolismofbreastcanceranditsimplicationsintcellimmunotherapy
AT cunjunmai targetingmetabolismofbreastcanceranditsimplicationsintcellimmunotherapy
AT zhiqinlin targetingmetabolismofbreastcanceranditsimplicationsintcellimmunotherapy
AT jianzhou targetingmetabolismofbreastcanceranditsimplicationsintcellimmunotherapy
AT guielai targetingmetabolismofbreastcanceranditsimplicationsintcellimmunotherapy